Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
  Breaking News: FDA Approves Triumeq, New Once-Daily Combination Pill
  
  • Email Email
  • Comments Comments
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

News

Reducing the Risk for HIV, Hepatitis C Among Injection Drug Users in New York

April 24, 2014

This article was reported by Infectious Disease Special Edition.

Infectious Disease Special Edition reported on a study showing that education and counseling services can control risky behaviors such as needle sharing in injection drug users (IDUs) and thus prevent HIV and hepatitis C virus (HCV) transmission in this high-risk community. Researchers at New York University's Center for Drug Use and HIV Research evaluated the efficacy of their Staying Safe Intervention, which was based on findings of a previous study in which they observed behaviors of IDUs.

The researchers enrolled 68 IDUs in a five-session Staying Safe education program. The program included safe injecting strategies, HIV and HCV risk in injection drug use, and ways of managing the risks. Of the 68 IDUs, 46 percent attended all sessions and 87 percent attended at least one session.

View Full Article


  
  • Email Email
  • Comments Comments
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

 
See Also
More New York HIV Prevention Policy News

No comments have been made.
 

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)

Your Name:


Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:

Tools
 

Advertisement